McGrathNicol
Australian restructuring and insolvency advisory firm handling receiverships and administrations.
On the record
Checkpoint: Resolution of Healthscope hospital receivership sale process
The call
McGrathNicol's statutory appointment work sits behind licensing and audit-conflict rules that AI and Big-4 firms cannot cross, while its Deals and Cyber lines face ordinary competitive pressure.
McGrathNicol handles company rescues, liquidations, and fraud investigations in Australia. The company has two real shields: it holds licenses that Big-4 firms like Deloitte and KPMG cannot get when they already audit a client, and someone must personally sign off on bankruptcy cases by law, which no AI can do. The pressure point is that some of McGrathNicol's newer work like cyber consulting and performance improvement sits in zones where Big-4 firms can compete directly and where AI tools may eventually shrink the junior jobs that feed the firm's pipeline.
Why
01
AI pressure: AI document-review and due-diligence tools (e.g. Harvey, Relativity aiR) used in deals and forensic work. AI speeds document review and forensic analysis, cutting junior-analyst hours in Deals and Cyber, but cannot hold a statutory appointment. Could AI do the core job? Unlikely.
02
Bigger players: Big-4 restructuring arms (Deloitte, KPMG, PwC, EY) and FTI Consulting. Big-4 firms already compete for unconflicted restructuring, cyber and performance-improvement work outside audit-client mandates. Could a giant copy it? No, they are blocked.
03
What protects it. Corporations Act licensing and personal liability for receivers and administrators, plus audit-independence rules barring Big-4 firms from their own audit clients' distressed mandates.
What would change this call
Whether new partner hires join Restructuring versus Deals, Cyber, or Performance practice lines. Shows if growth stays in the protected statutory-appointment core or shifts to contested Big-4-overlap areas.
Outcome of the Healthscope receivership sale process appointed May 2025. Tests McGrathNicol's ability to execute Australia's largest private hospital receivership.
Continuation or reversal of quarterly partner-cohort growth (Feb 2025, Aug 2025, Oct 2025, June 2026). A reversal would signal senior departures or contraction in the firm's talent base.
Outcome of the Healthscope receivership sale process appointed May 2025. Tests McGrathNicol's ability to execute Australia's largest private hospital receivership.
Continuation or reversal of quarterly partner-cohort growth (Feb 2025, Aug 2025, Oct 2025, June 2026). A reversal would signal senior departures or contraction in the firm's talent base.
Key numbers
- 497 employees firmwide
- A$100M CBA funding to run 37+ Healthscope hospitals
- Joined Eight International network across ~30 countries
Named risks
- Outcome of ongoing Healthscope receivership and hospital sale process remains unresolved as of May 2025 appointment.
- Mineral Commodities Ltd administration faces ASIC financial reporting deferrals as of April 2026, could end in liquidation.
- AI-driven automation of data-heavy forensic and analytics work could erode junior analyst hours in Deals, Performance and Forensic practice lines.
- No audited public financials exist for a private partnership, limiting external verification of financial health.
- Quarterly partner cohort growth pattern could reverse if senior partners depart, a trend the firm itself flags as a risk indicator.
Rivals, as read in July 2026
| Rival | Direction | Evidence |
|---|---|---|
| KordaMentha | contesting | KordaMentha had over 70 partners and ~600 staff by 2025 versus McGrathNicol's 497 staff by June 2026 |
| FTI Consulting | contesting | NYSE-listed FTI acquired KordaMentha's Queensland assets in October 2012 to build its Australian restructuring arm |
| Big 4 restructuring arms (Deloitte, KPMG, PwC, EY) | gaining on | Auditor independence rules bar Big 4 firms from restructuring their own audit clients, routing conflicted mandates to McGrathNicol |
Questions people ask
- Is McGrathNicol profitable in 2026?
- McGrathNicol is a private partnership with no audited public financials, so profitability cannot be independently confirmed. It generates fees from active mandates including the May 2025 Healthscope receivership and December 2025 Mineral Commodities administration, and grew to 64 partners by June 2026, suggesting continued fee-earning activity.
- Could AI replace McGrathNicol's restructuring work?
- No. Under Australia's Corporations Act 2001, Receiver, Voluntary Administrator, and Liquidator roles require named, licensed individuals with personal legal liability, which cannot be held by software. McGrathNicol instead uses AI internally, building a fraud detection and risk scoring tool for a client, per a September 2025 company post.
- Who owns McGrathNicol?
- McGrathNicol is a private partnership, not publicly listed or venture backed. Jason Preston serves as Executive Chair as of a June 2024 firm announcement. In March 2025 it joined Eight International, a France headquartered advisory network, as a membership affiliation rather than an ownership change.
- Is McGrathNicol growing or shrinking its workforce?
- Growing. Third party tracking shows headcount rising from about 392 in February 2023 to 497 by June 2026, roughly 5 percent year over year. Partner count climbed from 55 in November 2024 to 64 after a June 2026 round of five new partner appointments.
- Who is McGrathNicol's biggest competitor?
- KordaMentha, a Melbourne founded rival with over 70 partners and around 600 staff by 2025, is McGrathNicol's closest independent peer, alongside FTI Consulting, a NYSE listed firm that acquired KordaMentha's Queensland assets in 2012 to build its Australian restructuring practice.
- What is McGrathNicol's biggest recent mandate?
- McGrathNicol was appointed Receiver and Manager to Healthscope's parent hospital operator entities on May 26, 2025, one of Australia's largest ever private hospital receiverships, with an added A$100 million CBA funding package to keep more than 37 hospitals operating during the sale process.
Timeline
- 2026-06-29Appoints five new partners, four internal promotions and one lateral hire, taking partner count to 64
- 2026-04-24Mineral Commodities administration continues with ASIC financial reporting deferrals
- 2025-12-18Appointed Receivers/Administrators for Mineral Commodities Ltd (ASX: MRC)
- 2025-11-17Publishes Ransomware Survey with YouGov showing average ransom payments nearly halved
- 2025-10-08Appoints new Perth partner, expanding Deals Advisory offering
- 2025-08-25Appoints new Restructuring and Forensic partners, partner count reaches 56
- 2025-05-26Appointed Receiver and Manager to Healthscope parent entities with A$100M CBA funding
- 2025-03-06Joins Eight International global advisory network alongside DH Advisory
- 2025-02-21Appointed Receivers/Managers for Strandline Resources (ASX: STA)
- 2025-02-19Appointed Receivers/Administrator for Field Solutions Holdings (ASX: FSG)
- 2025-02-11Opens new Adelaide office
Revision history
30 July 2026
First assessed. Hard to displace. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources
- The History of McGrathNicol (2024-07-01)
- McGrathNicol Revenue, Funding & Valuation
- McGrathNicol - Headcount, Funding & Open Jobs (2026-06-23)
- Eight International adds McGrathNicol and DH Advisory to its network (2025-03-06)
- McGrathNicol appoints three new Partners (2024-06-28)
- Revenue, Competitors, Alternatives (2022-04-16)
- Receivers appointed to Healthscope parent companies (2025-05-26)
- ASX Announcement (2025-12-18)
- 250217-FSG-MediaRelease (2025-02-19)
- ASX Announcement (2025-02-21)
- McGrathNicol appoints five new Partners (2026-06-29)
- McGrathNicol appoints new Performance Improvement Partner (2025-02-11)